MDXG (MDXG) Stock Analysis
Verdict: HOLD
High gross margins and $166.1M cash cushion valuation risk, but consecutive quarterly earnings misses limit upside.
Investment score: 51/100
MiMedx balances strong balance sheet cash ($166.12M) and high gross margins (78.85%) against recent quarterly operational losses that inflate trailing P/E to 117.50x.
Peers
| Peer | P/E | P/B | P/S | EV/EBITDA | ROIC % | Net margin % |
|---|---|---|---|---|---|---|
| NVCT | -16.85 | 57.04 | 0.00 | -19.48 | — | 0.00 |
| GYRE | -35.12 | 5.39 | 6.52 | -52.68 | — | -0.15 |
| AURA | -3.81 | 2.04 | 0.00 | -4.94 | — | 0.00 |
| NGNE | -6.47 | 3.70 | 0.00 | -4.32 | — | 0.00 |
| IRWD | 5.40 | -4.39 | 1.82 | 4.24 | — | 0.33 |